{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The pathological hallmark of Parkinson's disease is the deposition of amyloid fibrils of alpha-synuclein. Mutations in alpha-synuclein affect its aggregation and are linked to PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that alpha-synuclein aggregation leads to Lewy bodies, relevant for PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Techniques include quenched hydrogen/deuterium exchange and NMR spectroscopy.",
          "judgment": "Yes",
          "reasoning": "Methods model disease mechanism by assessing protein structure and aggregation."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Assays used are standard in the field for studying protein structures.",
          "judgment": "Yes",
          "reasoning": "Techniques are accepted historically, supporting PS3."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analysis or OddsPath calculation provided.",
          "judgment": "Proceed to Sub-step 4b",
          "reasoning": "Insufficient data on controls; strength is PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "A30P mutation likely contributes to PD through altered aggregation, supported by functional assays."
    }
  ]
}